Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Natural Immunity and Protection Against the Delta Variant: A Retrospective Cohort Study
Priscilla Kim, Steven M. Gordon, Megan Sheehan, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e185-e190
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1161-1179
Open Access | Times Cited: 531
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
Heba N. Altarawneh, Hiam Chemaitelly, Mohammad R. Hasan, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 13, pp. 1288-1290
Open Access | Times Cited: 259
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 232
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May–November 2021
Tomás M. León, Vajeera Dorabawila, Lauren Nelson, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 4, pp. 125-131
Open Access | Times Cited: 143
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 135
Risk of reinfection and disease after SARS‐CoV‐2 primary infection: Meta‐analysis
Maria Elena Flacco, Cecilia Acuti Martellucci, Valentina Baccolini, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 10
Open Access | Times Cited: 74
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 67
Severity and Outcomes of SARS-CoV-2 Reinfection Compared with Primary Infection: A Systematic Review and Meta-Analysis
Jie Deng, Yirui Ma, Qiao Liu, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3335-3335
Open Access | Times Cited: 42
The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine
Sivan Gazit, Roei Shlezinger, Galit Perez, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 5, pp. 674-681
Open Access | Times Cited: 53
Vaccine mandates for healthcare workers beyond COVID-19
Alberto Giubilini, Julian Savulescu, Jonathan Pugh, et al.
Journal of Medical Ethics (2022) Vol. 49, Iss. 3, pp. 211-220
Open Access | Times Cited: 34
SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants
Osman Özüdoğru, Yasemin Genç Bahçe, Ömer Acer
Irish Journal of Medical Science (1971 -) (2022) Vol. 192, Iss. 2, pp. 751-756
Open Access | Times Cited: 32
Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant
Heba N. Altarawneh, Hiam Chemaitelly, Patrick Tang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
The unnaturalistic fallacy: COVID-19 vaccine mandates should not discriminate against natural immunity
Jonathan Pugh, Julian Savulescu, Rebecca C. H. Brown, et al.
Journal of Medical Ethics (2022) Vol. 48, Iss. 6, pp. 371-377
Open Access | Times Cited: 30
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States
Manuela Di Fusco, Kinga Marczell, Kristen A. Deger, et al.
Journal of Medical Economics (2022) Vol. 25, Iss. 1, pp. 605-617
Open Access | Times Cited: 26
Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers
Fotinie Ntziora, Evangelia Georgia Kostaki, Αmalia Karapanou, et al.
Vaccine (2022) Vol. 40, Iss. 50, pp. 7195-7200
Open Access | Times Cited: 22
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 21
Previous SARS-CoV-2 infections and their impact on the protection from reinfection during the Omicron BA.5 wave – a nested case-control study among vaccinated adults in Sweden
Fredrik Kahn, Carl Bonander, Mahnaz Moghaddassi, et al.
IJID Regions (2024) Vol. 10, pp. 235-239
Open Access | Times Cited: 3
Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics
J Zhang
Heliyon (2024) Vol. 10, Iss. 14, pp. e34577-e34577
Open Access | Times Cited: 3
Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies
Louis Nevejan, Lize Cuypers, Lies Laenen, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 8, pp. 1729-1731
Open Access | Times Cited: 16
Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data
Shannon L. Reynolds, Harvey W. Kaufman, William A. Meyer, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0280584-e0280584
Open Access | Times Cited: 9
Hybrid immunity against COVID-19 in different countries with a special emphasis on the Indian scenario during the Omicron period
Manojit Bhattacharya, Ashish Ranjan Sharma, Kuldeep Dhama, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108766-108766
Open Access | Times Cited: 15
Moralization and Mismoralization in Public Health
Steven R. Kraaijeveld, Euzebiusz Jamrozik
Medicine Health Care and Philosophy (2022) Vol. 25, Iss. 4, pp. 655-669
Open Access | Times Cited: 15
Major Update 2: Antibody Response and Risk for Reinfection After SARS-CoV-2 Infection—Final Update of a Living, Rapid Review
Haley K Holmer, Katherine Mackey, Celia Fiordalisi, et al.
Annals of Internal Medicine (2022) Vol. 176, Iss. 1, pp. 85-91
Open Access | Times Cited: 15
Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents
Tal Patalon, Yaki Saciuk, Galit Perez, et al.
The Journal of Pediatrics (2023) Vol. 257, pp. 113371-113371
Open Access | Times Cited: 8
Protective effectiveness of previous infection against subsequent SARS-Cov-2 infection: systematic review and meta-analysis
Weihua Hu, Huanle Cai, Huan-Chang Yan, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top